Legala is a legal practice management software designed to streamline various aspects of law firm operations. It offers features such as matter management, time recording, document management, email management, automated forms, client accounting, billing, reporting, and support for remote working. These functionalities aim to enhance productivity and service quality within legal practices.

We are developing a platform to help owners of renewable power plants and their service providers gaining access to the right information at the right time, enabling the right decisions. In order to achieve this we deconstruct the hundreds of documents describing each plant into snippets of information in accordance with our domain-driven data model. In the next 7 years, the world needs to invest almost twice what has been invested into renewable energy generation in the last 20 years. At the same time subsidies are being rolled back, increasing the need to for ensuring that projected ROI is not compromised by underperformance of the investments (i.e. plants). We have lived the pain, and know that NOW is the time to transform the way commercial management of renewable energy plants is being done.

New drugs for treating diseases of Down syndrome. More than 1% of the global GDP is spent on nursing demented people, and the number requiring nursing will triple within 2050. The disease is progressive, leading to death. There is no current cure available, only symptomatic treatments. Individuals born with Down syndrome have a more than 10x risk of developing dementia as well as a host of other diseases including diabetes. Our drug target, DYRK1A is an enzyme found on chromosome 21, and is considered a key factor determining developmental and medical challenges faced by individuals with Down. The enzyme interacts with multiple biological mechanisms involved in Alzheimer’s and autoimmune diseases. Advanced drug designUsing advanced drug design technologies, we have designed a potent DYRK1A inhibitor drug, PST-900. A use and substance of matter patent have been applied for. The company is currently working on chemical Lead Optimisation with 8 full-time medicinal chemists contracted.Financing and milestonesThe Company raised NOK 5 million in 2015 and 8.8 MNOK in 2016/2017, matching non-dilutive research (BIA) and business grants (Innovation Norway). We demonstrated Proof of Principle in a model system for Alzheimer’s disease in 2Q2016. We have also demonstrated that our drug is capable of reversing diabetes in an animal model. Together with clinical and regulatory advisors, we have identified an important unmet need for a drug to treat newly diagnosed diabetes. We will use this indication to quickly progress to market and from there develop analogous drug molecules in Alzheimer’s disease, focused especially in Down syndrome. Funding soughtThe current funding round will raise 15+ MNOK to fund the progression to the final Development Candidate during 2018. Following this, further funding will be sought to perform toxicology/safety and Phase 1 clinical studies. A highly experienced teamThe team behind Pharmasum Therapeutics have broad, international pharmaceutical and biotechnology experience, and is supported by an excellent group of advisors. Anders Fugelli, Ph.D., CEO. John Sigurd Svendsen, Ph.D., CSO. Pauline Stewart-Long, Ph.D. Project Management. Henning Mork, CFO. Board of Directors: Andrew Parsons, PhD. Øystein Soug, MSc. Mark Treherne, PhD, John Sigurd Svendsen, PhD.

50% of the population will encounter mental illness, but 65% leave treatment without results. We're here to change that. Mindcare develops Konfidens – the worlds first holistic mental healthcare platform designed to improve the effectiveness of psychological treatment. Our SaaS platform for psychologists combines the basic tools needed to administer a private practice, with novel research-based treatment instruments. Right now we are working on a module for psychometric symptom analysis based on clinical research, an algorithm matching patient and therapist based on empirical treatment data and a suite of tools to aid the therapists professional development. We are an ambitious team of psychology specialists, business developers and an advisory board with industry specialists. You can take a look at our team here: https://www.konfidens.no/team. Mindcare is backed by Innovation Norway, Aleap and several private investors. We are now hiring our first team members. We're looking for two talented developers to join our company as co-founders and help build the organization and product. Is this you or someone you know? Get in touch!

Succeeding with your company is not only about building a great product, but also about finding the right investors. This is what we want to help growth companies with - if we can match them with the right people, they can get the help and funding they need to ensure their success. As a company we are young and ambitious - a small team of startup founders, investors and technologists with big plans. We believe there’s a better way for companies and investors to meet and collaborate, and we are building a platform to enable this. We strive for an inclusive and collaborative culture that celebrates curiosity and new ideas. We love that we are a multidisciplinary bunch with different skills and experiences, and we really believe in giving everyone the freedom to contribute with what they’re great at.

Oslo Business Region is the official business development agency of Oslo municipality (Oslo kommune). The organization supports and builds the startup and innovation ecosystem through city marketing, investment and talent attraction. Oslo Business Region knows Oslo and the startup and innovation ecosystem. We provide insight and access to local and international business networks through digital platforms, events and support services. Our ambition is to create and scale more high-growth companies in the region, leading to new jobs and sustainable solutions that solve global challenges. We develop and build international awareness of Oslo as an attractive and sustainable destination for business, investment and talent.

Sharebox develop, manufacture and operate an automatic exchange service for keys and other small items. The service is completely App controlled and allows you to rent a box and share access with others in a safe and convenient way, just by using your smartphone. To get started simply download the App or visit our website. The service is available at selected convenience stores in Europe, Car-Rental locations and Car-Workshops providing an around-the-clock access.  Sharebox was established in February, 2016 by the founder and inventor Arne Eivind Andersen and his co-founder Leif Arne Dalane. Since then the Sharebox team has been working non-stop to bring their vision to life. The original idea was triggered by a genuine need for a key exchange service in Manhattan. Our approach was to develop a simple but unique concept based on current technology and creative minds. The result was an exchange service completely managed by phone. The first of its kind. Our service includes a Sharebox locker and a Sharebox App, specifically designed for this purpose. Do you want to learn more about us – and what we do? Let us know and we’ll be more than happy to share it with you.

Young Sustainable Impact (YSI) was started in 2016 by a group of youth in Norway who saw the cop21, Paris conference and looked ahead.We believe innovation and entrepreneurship can solve most of our challenges in the world, that youth are the driving force, and in collaboration with the experienced and established – it can be done. Innovation program: We aim to find the best talents in the world, to create impact startups to tackle the UN Sustainable Development Goals.  In Oslo we are a group of very different people, who somehow ended up together, with the same mission. We have fun, excited people who are trying their best to help people and at the same time grow into becoming that person who can influence the world in a positive direction. It's about the main goal, and not being recognized yourself - which is why any disagreement we have, turns out in a positive energy. The power of trying to get YSI to do the most good, is vital! We have found a great spot in Greenhouse, with a gaming room, ping pong, garden on the roof, (A ROOF), and other cool companies from all fields imaginable.At the same time, we work with teams in Bangladesh, South-East Asia, and China. Extremely different cultures, who also have the same goal as us. This is both hard and exciting at the same time.

Sanna eliminates accounting headaches for entrepreneurs. Our authorized accountants handle all bookkeeping, tax filings, and annual reports for holding companies, at the cost of DIY software. We're on a mission to let founders focus on building, not bookkeeping. Backed by Norway's top company builders.

Monio AS (org. nr. 913 978 617) er et heleid datterselskap av SpareBank 1 SR-Bank ASA (org. nr. 937 895 321). Monio AS formidler lån til små og mellomstore bedrifter og er regulert av Finanstilsynet med tillatelse til å drive virksomhet som betalingsforetak og er registrert som låneformidler. Som lånformidler er Monio ikke en part i låneavtalen mellom långiver og låntaker.

OncoImmunity is a bioinformatics company providing unique machine-learning software to identify tumor-specific mutations that can be targeted by a patient’s own immune system (known as neoantigens). The OncoImmunity solution is important because recent breakthroughs in the field of Immuno-Oncology (I-O) such as the development of checkpoint inhibitors and personalized cancer vaccines, clearly demonstrate that a patient’s immune system can be harnessed to successfully treat cancer. The cost of identifying tumor-specific mutations in a patient’s cancer using next-generation sequencing (NGS) is now trivial and this technology will be key to enabling truly personalized immunotherapies to be developed in a technically and economically feasible manner. However, the remaining challenge that currently limits the field, and which is addressed by the OncoImmunity solution, is predicting which tumor-specific mutations can stimulate a patient’s immune system i.e. are immunogenic. Using NGS data as input, the OncoImmunity software enables accurate patient selection for cancer immunotherapy and can identify optimal targets for personalized cancer vaccines & cell therapies in a clinically actionable time frame. Beginning from this first product offering, OncoImmunity has the vision to become the world’s leading provider of software to guide cancer immunotherapy to improve survival rates for cancer patients. To achieve this OncoImmunity has assembled a growing team of world-class bioinformaticians, data scientists, and software engineers; developing its cutting-edge machine-learning technology that will help fulfill the promise of immunotherapy in the fight against cancer. OncoImmunity’s technology will disrupt the I-O field by offering regulatory-compliant prediction software on a software-as-a-service basis (SaaS). This will allow big pharma, biotechnology, and immunotherapy companies of any size to access OncoImmunity’s cutting-edge prediction software. The company is headquartered in an ideal scientific and entrepreneurial ecosystem to develop its technology at the Oslo Cancer Cluster Incubator; adjacent to the Institute for Cancer Research and the Norwegian Radium Hospital. OncoImmunity is a privately held company, founded in 2014 by experienced bioinformatics scientists (Dr. Trevor Clancy and Professor Eivind Hovig), and an experienced immunologist with a business development background (Dr. Richard Stratford). The company is backed by private financing from the Norwegian Radium Hospital Research Foundation, the Norwegian Cancer Society, STARTUPLAB, and Grotmol Solutions, in addition to a number of private software investors. The company is also supported by grants awarded from the Norwegian Research Council, Innovation Norway, and the EU. The company has already established both national and international collaborations and pilot projects to develop further proof-of-concept data and validate its software.

CURRENT was founded with a vision to make owning and managing EV chargers easy and accessible. Since 2013, we have been working to solve the challenges related to charging infrastructure by bringing together the tools and expertise needed to manage and operate charging points in one place. Today, we have helped over 150,000 users with more than 20,000 charging points across seven different countries.

Kavall is your on-demand local supermarket, delivering groceries to your door in 10 minutes. We do this through our own dark stores and with the help of our employed Riders on e-bikes. By offering groceries at the moment you need them, Kavall is redefining an industry that has remained untouched over the last decades. Launched in March 2021, we are a vibrant team of visionaries that is growing day by day. By joining us, you’ll enter a high-paced, developing an environment where your work instantly makes an impact on someone’s life. Join the ride!

At Speiz we are driving the future of Commercial Real Estate Space Leasing. By aggregating and consolidating data, we provide our customers with complete market overview and digital tools to make data-driven decisions in market that is extremely fragmented and dominated by dinosaur-companies relying on manual processes. We believe the future of commercial real estate is digital and we believe Warehouse and Logistics Space will become the most important segment in of the industry - the one segment that is key in enabling ever-growing online sales and the rise of consumer-centric businesses delivering more and more products and services at the consumers doorstep. This is why we are on a mission to create the world's first data-driven leasing platform for Warehouse & Logistics space.

At Fornix, we aim to improve the quality of mental health across the globe by making treatments safer, controllable, more efficient, and widely available to everyone. Utilizing the strengths of XR technology we develop these tools together with mental health experts and hospitals/polyclinics. We consist of a strong and diverse team made up of engineers, psychologists, designers, animators, and more. If you are interested in learning more you can visit our site at: https://fornixvr.com Or reach out to us directly via: hello@fornixvr.com